Free Trial

Lifecore Biomedical (LFCR) Competitors

Lifecore Biomedical logo
$8.19 -0.03 (-0.36%)
As of 07/8/2025 04:00 PM Eastern

LFCR vs. GPCR, CVAC, CALT, AUPH, BGM, NAGE, AMPH, DYN, ABCL, and PAHC

Should you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include Structure Therapeutics (GPCR), CureVac (CVAC), Calliditas Therapeutics AB (publ) (CALT), Aurinia Pharmaceuticals (AUPH), BGM Group (BGM), Niagen Bioscience (NAGE), Amphastar Pharmaceuticals (AMPH), Dyne Therapeutics (DYN), AbCellera Biologics (ABCL), and Phibro Animal Health (PAHC). These companies are all part of the "pharmaceutical products" industry.

Lifecore Biomedical vs. Its Competitors

Lifecore Biomedical (NASDAQ:LFCR) and Structure Therapeutics (NASDAQ:GPCR) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Lifecore Biomedical has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Structure Therapeutics has a beta of -1.87, meaning that its stock price is 287% less volatile than the S&P 500.

Structure Therapeutics has a net margin of 0.00% compared to Lifecore Biomedical's net margin of -35.90%. Structure Therapeutics' return on equity of -16.35% beat Lifecore Biomedical's return on equity.

Company Net Margins Return on Equity Return on Assets
Lifecore Biomedical-35.90% -551.09% -13.89%
Structure Therapeutics N/A -16.35%-15.71%

In the previous week, Structure Therapeutics had 2 more articles in the media than Lifecore Biomedical. MarketBeat recorded 3 mentions for Structure Therapeutics and 1 mentions for Lifecore Biomedical. Structure Therapeutics' average media sentiment score of 0.56 beat Lifecore Biomedical's score of 0.00 indicating that Structure Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Lifecore Biomedical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Structure Therapeutics
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Lifecore Biomedical has higher revenue and earnings than Structure Therapeutics. Structure Therapeutics is trading at a lower price-to-earnings ratio than Lifecore Biomedical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lifecore Biomedical$128.26M2.36$12.01M-$1.45-5.65
Structure TherapeuticsN/AN/A-$122.53M-$0.87-21.54

83.4% of Lifecore Biomedical shares are held by institutional investors. Comparatively, 91.8% of Structure Therapeutics shares are held by institutional investors. 32.2% of Lifecore Biomedical shares are held by insiders. Comparatively, 9.4% of Structure Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Lifecore Biomedical presently has a consensus target price of $8.00, indicating a potential downside of 2.32%. Structure Therapeutics has a consensus target price of $76.17, indicating a potential upside of 306.44%. Given Structure Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Structure Therapeutics is more favorable than Lifecore Biomedical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lifecore Biomedical
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
Structure Therapeutics
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Structure Therapeutics beats Lifecore Biomedical on 9 of the 15 factors compared between the two stocks.

Get Lifecore Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFCR vs. The Competition

MetricLifecore BiomedicalMED IndustryMedical SectorNASDAQ Exchange
Market Cap$304.35M$2.87B$5.47B$8.95B
Dividend YieldN/A2.46%5.25%4.04%
P/E Ratio-5.6520.8026.9620.11
Price / Sales2.36286.27430.20119.79
Price / CashN/A41.1936.8257.86
Price / Book22.147.487.985.56
Net Income$12.01M-$55.04M$3.16B$248.40M
7 Day Performance1.87%2.44%2.39%4.67%
1 Month Performance20.80%1.90%2.18%6.64%
1 Year Performance62.82%4.35%33.82%21.31%

Lifecore Biomedical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFCR
Lifecore Biomedical
0.9959 of 5 stars
$8.19
-0.4%
$8.00
-2.3%
+63.8%$304.35M$128.26M-5.65690
GPCR
Structure Therapeutics
2.6781 of 5 stars
$20.74
-1.6%
$76.17
+267.2%
-49.7%$1.21BN/A-23.84136
CVAC
CureVac
4.4976 of 5 stars
$5.43
+0.9%
$6.83
+25.8%
+73.2%$1.21B$579.18M5.90880
CALT
Calliditas Therapeutics AB (publ)
N/A$40.00
flat
N/AN/A$1.19B$1.60B-21.62180
AUPH
Aurinia Pharmaceuticals
2.5668 of 5 stars
$8.47
-2.0%
$11.50
+35.8%
+34.8%$1.17B$235.13M30.25300
BGM
BGM Group
N/A$10.59
-11.5%
N/AN/A$1.16B$25.10M0.00298Analyst Downgrade
NAGE
Niagen Bioscience
1.2976 of 5 stars
$14.41
+1.3%
$19.50
+35.3%
N/A$1.12B$99.60M84.76120
AMPH
Amphastar Pharmaceuticals
4.4152 of 5 stars
$22.96
-0.5%
$32.33
+40.8%
-39.5%$1.09B$731.97M8.322,028
DYN
Dyne Therapeutics
3.644 of 5 stars
$9.52
-0.5%
$41.13
+332.0%
-75.0%$1.09BN/A-2.65100
ABCL
AbCellera Biologics
2.5473 of 5 stars
$3.43
-5.0%
$8.33
+143.0%
+41.5%$1.08B$28.83M-6.12500News Coverage
Analyst Forecast
High Trading Volume
PAHC
Phibro Animal Health
3.6799 of 5 stars
$25.54
-0.5%
$21.80
-14.6%
+71.9%$1.04B$1.02B32.741,940Trending News
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:LFCR) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners